×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AVDL – avadel pharmaceuticals plc - american depositary shares each representing one ordinary share (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AVDL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/12
07:50 am
avdl
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market [Yahoo! Finance]
Low
Report
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market [Yahoo! Finance]
2/10
04:05 pm
avdl
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing
Low
Report
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing
1/13
09:38 pm
avdl
Rechecking Avadel Pharmaceuticals (AVDL) Valuation After Strong Share Price Momentum [Yahoo! Finance]
Low
Report
Rechecking Avadel Pharmaceuticals (AVDL) Valuation After Strong Share Price Momentum [Yahoo! Finance]
1/12
04:05 pm
avdl
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
Low
Report
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
1/9
10:01 am
avdl
Do Options Traders Know Something About Avadel Pharmaceuticals Stock We Don't? [Yahoo! Finance]
Low
Report
Do Options Traders Know Something About Avadel Pharmaceuticals Stock We Don't? [Yahoo! Finance]
1/7
02:31 am
avdl
Why Analysts See The Alkermes (ALKS) Story Shifting After Avadel Deal And Orexin Data [Yahoo! Finance]
Neutral
Report
Why Analysts See The Alkermes (ALKS) Story Shifting After Avadel Deal And Orexin Data [Yahoo! Finance]
12/20
11:28 am
avdl
Assessing Avadel Pharmaceuticals (AVDL) Valuation After Strong 1-Year Share Price Performance [Yahoo! Finance]
Low
Report
Assessing Avadel Pharmaceuticals (AVDL) Valuation After Strong 1-Year Share Price Performance [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
8/7/2025
07:00 am
avdl
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
BEAT
Report
14.8%
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
5/7/2025
07:00 am
avdl
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
BEAT
Report
5.7%
avadel pharmaceuticals plc - american depositary shares each representing one ordinary share
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/12
05:37 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Rodriguez Susan
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Rodriguez Susan
2/12
05:36 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Thornton Peter J.
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Thornton Peter J.
2/12
05:36 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Seurer Jerad G.
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Seurer Jerad G.
2/12
05:35 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Palczuk Linda
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Palczuk Linda
2/12
05:34 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: McCamish Mark Anthony
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: McCamish Mark Anthony
2/12
05:34 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: MCHUGH THOMAS S
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: MCHUGH THOMAS S
2/12
05:33 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Glass Geoffrey Michael
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Glass Geoffrey Michael
2/12
05:33 pm
avdl
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Ende Eric J
Neutral
Report
Form 4 AVADEL PHARMACEUTICALS For: Feb 12 Filed by: Ende Eric J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/21
Avadel Pharmaceuticals Announces $65 Million Private Placement with Leading Biotech Investment Funds
32.0%
6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%
6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%
3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%
9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%
6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%
5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%
9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%
11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%
4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%
6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%
6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%
3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%
9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%
6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%
5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%
9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%
11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%
4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%
TOP News Decliners
3/12
Q4/2019 12/31/2019 EPS -0.070 ZacksConsensus -0.250 ActVsEst 0.180 - Beat
-20.7%
4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%
4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%
8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%
7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%
6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%
9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%
11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%
10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%
8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%
4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%
4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%
8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%
7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%
6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%
9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%
11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%
10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%
8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: